For assistance call us on: 0113 206 7503 Email us
Stereotactic Ablative Radiotherapy (SABR) is an advanced, non-invasive radiotherapy technique used to treat certain cancers, including lung metastases.
SABR delivers a highly precise, ablative dose of radiation over a small number of outpatient sessions (typically 3–8 treatments) with the aim of:
Improving tumour control
Minimising side effects to surrounding healthy tissue
SABR is:
Widely used internationally in North America, Europe, and Asia
Proven to achieve high rates of local tumour control (>90%)
Associated with low rates of side effects
In the UK, SABR is now used to treat oligometastatic disease, helping patients with 1–3 lung metastases who have a good prognosis from their primary cancer.
Our SABR service is led by Dr Kevin Franks and Dr Peter Dickinson, Consultant Clinical Oncologists at the St James’s Institute of Oncology.
Dr Kevin Franks completed a SABR Research Fellowship at the Princess Margaret Hospital, Toronto, and is one of the UK’s leading SABR clinicians.
Dr Peter Dickinson is a key member of the Leeds Lung SABR team and leads the Leeds Lung Oligometastatic SABR programme. He completed a technical radiotherapy research fellowship at the Christie Hospital, Manchester.
At Nova Healthcare, we offer SABR treatment for:
Brain tumours
Lung metastases
Selected oligometastatic cancers
At Nova, you will have a dedicated team of experts supporting you every step of the way, looking after both your physical and emotional wellbeing.
Learn more about the care we provide and our values [here].
If you have any questions or would like to book an appointment, contact us:
Phone: 0113 206 7503
Email: leedsth-tr.brachy-rt@nhs.net